연구성과로 돌아가기
2021 연구자 정보 (139 / 1146)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Nam, Joon Yeul (Nam, JY) |
Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea |
|
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Neff, Guy (Neff, G) |
Covenant Res, Sarasota, FL USA |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Nguyen, Anh-Hoa (Nguyen, AH) |
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA |
|
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
Nijhawan, Sandeep (Nijhawan, S) |
Sawai Man Singh Hosp, SMS Med Coll, Jaipur, Rajasthan, India |
|
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
Odin, Joseph (Odin, J) |
Mt Sinai Hosp, New York, NY 10029 USA |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Pacurar, Daniela (Pacurar, D) |
Grigore Alexandrescu Emergency Clin Hosp Children, Inst Med & Pharm, Bucharest, Romania |
IYS-1131-2023 Pacurar, Daniela |
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
Papatheodoridis, George (Papatheodoridis, G) |
Natl & Kapodistrian Univ Athens, Sch Med, Dept Gastroenterol, Gen Hosp Athens Laiko, Athens, Greece Natl & Kapodistrian Univ Athens, Sch Med, Gen Hosp Athens Laiko, Dept Gastroenterol, Athens, Greece |
A-4603-2008 Papatheodoridis, George |
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Park, Hyeung Keun (Park, HK) |
Jeju Natl Univ, Dept Hlth Policy & Management, Sch Med, Jeju, South Korea |
J-6839-2012 Park, Hui |
|
[JCR상위 4.8] Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | sejjoo@jejunu.ac.kr; | ||
|
Park, Jae Hong (Park, JH) |
Pusan Natl Univ, Childrens Hosp, Pusan, South Korea |
|
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
Park, Jun Yong (Park, JY) |
Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsel Liver Ctr, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea Yonsei Univ, Dept Internal Med, Coll Med, Seoul 03722, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul 03722, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul 03722, South Korea Yonsei Univ, Yonsei Liver Ctr, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea |
H-7127-2019 Park, Jun |
0000-0001-6324-2224 Park, Jun Yong |
[JCR상위 4.8] An episode of detectable serum hepatitis B virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of <2, 000 IU/ml [JCR상위 27.6] Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients [JCR상위 59.7] External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals [JCR상위 14.8] The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma [JCR상위 5.9] AN EXTERNAL VALIDATION OF FIBROSCAN-AST SCORE (FAST) FOR NON-INVASIVE IDENTIFICATION OF PATIENTS AT RISK OF PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS [JCR상위 59.7] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B [JCR상위 16.7] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B [JCR상위 59.7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir [JCR상위 24.3] Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease [JCR상위 48.0] Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma [JCR상위 60.8] Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study |
SCIE | 4.8 |
GASTROENTEROLOGY & HEPATOLOGY MEDICINE, GENERAL & INTERNAL GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY ONCOLOGY |
beomkkim@yuhs.ac; ksukorea@yuhs.ac; beomkkim@yuhs.ac;lorry-lee@yuhs.ac;sikarue@yuhs.ac;ksukorea@yuhs.ac;DRPJY@yuhs.ac; dh.sinn@samsung.com;ksukorea@yuhs.ac; beomkkim@yuhs.ac;psyoung0419@gmail.com; KSUKOREA@yuhs.ac; sikarue@yuhs.ac;sinndhn@hanmail.net;psyoung0419@gmail.com;HJSHIN105@yuhs.ac;lorry-lee@yuhs.ac;beomkkim@yuhs.ac;drpjy@yuhs.ac;dyk1025@yuhs.ac;ahnsh@yuhs.ac;mdflorence@yuhs.ac;ksukorea@yuhs.ac; |
||
|
Park, Soo Young (Park, SY) |
Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ Hosp, Dept Internal Med, Korea, South Korea Kyungpook Natl Univ, Sch Appl Chem Engn, Polymer Nanomat Lab, Dept Polymer Sci & Engn, 80 Daehak Ro, Daegu 41566, South Korea Kyungpook Natl Univ, Dept Internal Med, Sch Med, Kyungpook Natl Univ Hosp, Daegu 41944, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea Kyungpook Natl Univ, Dept Internal Med, Sch Med, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea |
N-3170-2017 park, soo-young |
0000-0002-4944-4396 0000-0001-6796-4929 Park, Soo Young park, soo-young |
[JCR상위 4.8] An episode of detectable serum hepatitis B virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of <2, 000 IU/ml [JCR상위 25.9] Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases [JCR상위 27.6] Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients [JCR상위 34.5] Biochar/polypropylene composites: A study on the effect of pyrolysis temperature on crystallization kinetics, crystalline structure, and thermal stability [JCR상위 37.9] Explaining Deep Learning-Based Traffic Classification Using a Genetic Algorithm [JCR상위 71.2] Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma [JCR상위 59.7] External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals [JCR상위 5.9] CIRCULAR NONCODING RNA HSACIRC₀₀₀₅₉₈₆ AS A PROGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA [JCR상위 5.9] CIRCULATING EXOSOMAL LNCRNA-ATB PROMOTES MYOPENIA IN HUMAN HEPATOCELLULAR CARCINOMA [JCR상위 14.8] The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma [JCR상위 5.9] AN EXTERNAL VALIDATION OF FIBROSCAN-AST SCORE (FAST) FOR NON-INVASIVE IDENTIFICATION OF PATIENTS AT RISK OF PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS [JCR상위 59.7] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B [JCR상위 16.7] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B [JCR상위 25.0] Circular noncoding RNA hsacᵢᵣc₀₀₀₅₉₈₆ as a prognostic biomarker for hepatocellular carcinoma [JCR상위 46.8] Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment [JCR상위 59.7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir [JCR상위 38.5] Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites [JCR상위 24.3] Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease [JCR상위 1.3] Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19 [JCR상위 32.0] A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records [JCR상위 48.0] Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma [JCR상위 60.8] Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study [JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B [JCR상위 0.2] Federated learning for predicting clinical outcomes in patients with COVID-19 |
SCIE | 0.2 |
GASTROENTEROLOGY & HEPATOLOGY MEDICAL LABORATORY TECHNOLOGY MEDICINE, GENERAL & INTERNAL MULTIDISCIPLINARY SCIENCES COMPUTER SCIENCE, INFORMATION SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY ONCOLOGY COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;ENGINEERING, BIOMEDICAL;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING BIOCHEMISTRY & MOLECULAR BIOLOGY;CELL BIOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL |
beomkkim@yuhs.ac; wytak@knu.ac.kr; ksukorea@yuhs.ac; aalghyamah@ksu.edu.sa;aelnour@ksu.edu.sa;shaider@ksu.edu.sa;hamshaikh@ksu.edu.sa;apoulose@ksu.edu.sa;szahrani@ksu.edu.sa;walmasry@ksu.edu.sa;psy@knu.ac.kr; chopro@hanyang.ac.kr; KeunHur@knu.ac.kr; beomkkim@yuhs.ac;lorry-lee@yuhs.ac;sikarue@yuhs.ac;ksukorea@yuhs.ac;DRPJY@yuhs.ac; dh.sinn@samsung.com;ksukorea@yuhs.ac; beomkkim@yuhs.ac;psyoung0419@gmail.com; magnolia1103@naver.com;KeunHur@knu.ac.kr; chung50@dsmc.or.kr;kbs9225@cu.ac.kr; KSUKOREA@yuhs.ac; jangha106@gmail.com; sikarue@yuhs.ac;sinndhn@hanmail.net;psyoung0419@gmail.com;HJSHIN105@yuhs.ac;lorry-lee@yuhs.ac;beomkkim@yuhs.ac;drpjy@yuhs.ac;dyk1025@yuhs.ac;ahnsh@yuhs.ac;mdflorence@yuhs.ac;ksukorea@yuhs.ac; li.quanzheng@mgh.harvard.edu; MKALRA@mgh.harvard.edu;Li.Quanzheng@mgh.harvard.edu; pindra@empal.com; mflores@nvidia.com; |
||
|
Rajicic, Natasa (Rajicic, N) |
Arrowhead Pharmaceut Inc, Pasadena, CA USA |
|
|
[JCR상위 4.8] ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | jhamilton@arrowheadpharma.com; | ||
|
Rha, Seung-Woon (Rha, SW) |
Korea Univ, Cardiovasc Ctr, Guro Hosp, Seoul, South Korea Korea Univ, Guro Hosp, Gurodong Ro, Seoul 08308, South Korea Guro Hosp, Seoul, South Korea Korea Univ, Guro Hosp, Seoul, South Korea Korea Univ, Cardiovasc Ctr, Dept Internal Med, Div Cardiol,Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea |
AGE-5810-2022 Rha, Seung-Woon |
0000-0001-9456-9852 Rha, Seung-Woon |
[JCR상위 4.8] Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction [JCR상위 39.3] Effects of Asian dust-derived particulate matter on ST-elevation myocardial infarction: retrospective, time series study [JCR상위 38.5] Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction [JCR상위 61.9] Clinical Implication of 'Obesity Paradox' in Elderly Patients With Acute Myocardial Infarction [JCR상위 4.8] Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention |
SCIE | 4.8 |
CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH MULTIDISCIPLINARY SCIENCES CARDIAC & CARDIOVASCULAR SYSTEMS |
sejjoo@jejunu.ac.kr; hokim@snu.ac.kr; mirinesilver@catholic.ac.kr; woongwa@yu.ac.kr; myungho@chollian.net;yasuda.satoshi.hp@ncvc.go.jp; |
||
|
Rosenthal, Philip (Rosenthal, P) |
Univ Calif San Francisco, San Francisco, CA 94143 USA |
AGG-3493-2022 Rosenthal, Philip |
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
San Martin, Javier (San Martin, J) |
Arrowhead Pharmaceut Inc, Pasadena, CA USA |
|
|
[JCR상위 4.8] ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | jhamilton@arrowheadpharma.com; |
페이지 이동: